These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11226414)

  • 21. Paraoxonase producing PON1 gene M/L55 polymorphism is related to autopsy-verified artery-wall atherosclerosis.
    Malin R; Järvinen O; Sisto T; Koivula T; Lehtimäki T
    Atherosclerosis; 2001 Aug; 157(2):301-7. PubMed ID: 11472729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mechanisms that protect against homocysteine toxicity].
    Zimny J
    Postepy Biochem; 2008; 54(1):91-8. PubMed ID: 18610586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
    Jakubowski H
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():155-67. PubMed ID: 19261978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The molecular basis of homocysteine thiolactone-mediated vascular disease.
    Jakubowski H
    Clin Chem Lab Med; 2007; 45(12):1704-16. PubMed ID: 17937605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum paraoxonase 1 activity and protein N-homocysteinylation in primary human endometrial cancer.
    Gałczyński K; Bełtowski J; Nowakowski Ł; Vasilevska D; Rechberger T; Semczuk A
    Tumour Biol; 2018 Sep; 40(9):1010428318797869. PubMed ID: 30178714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between PON1 L/M55 polymorphism and plasma lipoproteins in two Canadian aboriginal populations.
    Fanella S; Harris SB; Young TK; Hanley AJ; Zinman B; Connelly PW; Hegele RA
    Clin Chem Lab Med; 2000 May; 38(5):413-20. PubMed ID: 10952224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum PON-1 activity but not Q192R polymorphism is related to the extent of atherosclerosis.
    Bayrak A; Bayrak T; Tokgözoglu SL; Volkan-Salanci B; Deniz A; Yavuz B; Alikasifoglu M; Demirpençe E
    J Atheroscler Thromb; 2012; 19(4):376-84. PubMed ID: 22188760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of homocysteine thiolactone in some of human diseases].
    Sikora M; Twardowski T; Jakubowski H
    Postepy Biochem; 2006; 52(4):417-23. PubMed ID: 17536511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Processes of plasma protein N-homocysteinylation in multiple sclerosis.
    Jamroz-Wiśniewska A; Bełtowski J; Bartosik-Psujek H; Wójcicka G; Rejdak K
    Int J Neurosci; 2017 Aug; 127(8):709-715. PubMed ID: 27671515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans.
    Jakubowski H
    J Nutr; 2000 Feb; 130(2S Suppl):377S-381S. PubMed ID: 10721911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of paraoxonase 1 (PON1) activity and protein N-homocysteinylation by bisphosphonates in rats.
    Rusek M; Pastryk JE; Bełtowski J
    Chem Biol Interact; 2016 Nov; 259(Pt B):401-406. PubMed ID: 27387541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human valacyclovir hydrolase/biphenyl hydrolase-like protein is a highly efficient homocysteine thiolactonase.
    Marsillach J; Suzuki SM; Richter RJ; McDonald MG; Rademacher PM; MacCoss MJ; Hsieh EJ; Rettie AE; Furlong CE
    PLoS One; 2014; 9(10):e110054. PubMed ID: 25333274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between paraoxonase and homocysteine: crossroads of oxidative diseases.
    Yilmaz N
    Arch Med Sci; 2012 Feb; 8(1):138-53. PubMed ID: 22457688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between high-density lipoprotein paraoxonase gene M/L55 polymorphism and carotid atherosclerosis differs in smoking and nonsmoking men.
    Malin R; Loimaala A; Nenonen A; Mercuri M; Vuori I; Pasanen M; Oja P; Bond G; Koivula T; Lehtimäki T
    Metabolism; 2001 Sep; 50(9):1095-101. PubMed ID: 11555845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Association of paraoxonase polymorphisms and serum homocysteine thiolactone complex with coronary heart disease].
    Qin Q; Li YL; Zhao FM; Wang H; Li Y; Cui RZ; Zhao BR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):803-7. PubMed ID: 17217688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of HDL-bound and free PON1 on copper-induced LDL oxidation.
    Bayrak A; Bayrak T; Bodur E; Kılınç K; Demirpençe E
    Chem Biol Interact; 2016 Sep; 257():141-6. PubMed ID: 27510818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of the human paraoxonase polymorphism (PON1 192) on the carotid-wall thickening in a healthy population.
    Dessì M; Gnasso A; Motti C; Pujia A; Irace C; Casciani S; Staffa F; Federici G; Cortese C
    Coron Artery Dis; 1999 Dec; 10(8):595-9. PubMed ID: 10599538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human serum paraoxonase.
    Mackness B; Durrington PN; Mackness MI
    Gen Pharmacol; 1998 Sep; 31(3):329-36. PubMed ID: 9703197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of the C677T MTHFR polymorphism with homocysteine, ox-LDL levels, and thiolactonase activities in the severity of coronary syndrome.
    Koubaa N; Nakbi A; Hammami S; Mehri S; Attia N; Ben Farhat M; Hammami M
    Clin Appl Thromb Hemost; 2010 Oct; 16(5):515-21. PubMed ID: 20530057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The paraoxonase-1 codon 192 polymorphism is associated with fasting total cholesterol and LDL-cholesterol concentrations only in postmenopausal women. The REGICOR study.
    Senti M; Tomás M; Elosual R; Sala J; Masiá R; Marrugat J
    Clin Chem Lab Med; 2002 Jul; 40(7):677-83. PubMed ID: 12241013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.